Organoids are 3D in vitro culture systems derived from self-organizing stem cells. They can recapitulate the in vivo architecture, functionality, and genetic signature of original tissues. Thus, organoid technology has been rapidly applied to understanding stem cell biology, organogenesis, and various human pathologies. The recent development of human patient-derived organoids has enabled disease modeling with precision, highlighting their great potential in biomedical applications, translational medicine, and personalized therapy. In light of recent breakthroughs using organoids, it is only apt that we appreciate the advantages and shortcomings of this technology to exploit its full potential. We discuss recent advances in the application of organoids in studying cancer and hereditary diseases, as well as in the examination of host cell-microorganism interactions.
Trends Mol Med. 2017 May;23(5):393-410.
Dutta D, Heo I, Clevers H.
The Scientist, February 22, 2018
Nature Medicine. Sept 2017; Vol 23, Nr 9: 1028-1035
Cell. 2018 Jan 11;172(1-2):373-386.
Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):E6831-E6839.
Nature. 2016 Nov 24;539(7630):560-564.
Nat Mater. 2016 Mar;15(3):344-52
Subscribe to our newsletter
Stay up-to-date on the latest advancements in 3D cell culture technology